A double masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma

Br J Clin Pharmacol. 2001 Aug;52(2):210-2. doi: 10.1046/j.0306-5251.2001.01432.x.

Abstract

Aims: To investigate whether nifedipine affects ocular perfusion or visual fields in open angle glaucoma patients.

Methods: In a parallel group study nifedipine or placebo was administered for 3 months (n = 30). Ocular fundus pulsation amplitude (FPA), cup blood flow (Flowcup) and visual field mean deviation (MD) were measured.

Results: Five patients receiving nifedipine discontinued due to adverse events. Nifedipine did not affect FPA [difference: 0.3 microm (95% CI -0.3,0.9); P = 0.70], Flowcup: [difference: -9 rel.units (95% CI -133,114); P = 0.99], or MD [difference: 0.2dB (95% CI -2.2,2.7); P = 0.51] vs placebo.

Conclusions: Systemic nifedipine is not well tolerated in glaucoma patients and exerts no effect on visual fields or ocular perfusion.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Blood Flow Velocity
  • Calcium Channel Blockers / adverse effects
  • Calcium Channel Blockers / blood
  • Calcium Channel Blockers / therapeutic use*
  • Fundus Oculi
  • Glaucoma, Open-Angle / drug therapy*
  • Glaucoma, Open-Angle / physiopathology
  • Humans
  • Interferometry / methods
  • Intraocular Pressure
  • Laser-Doppler Flowmetry
  • Nifedipine / adverse effects
  • Nifedipine / blood
  • Nifedipine / therapeutic use*
  • Optic Nerve / blood supply
  • Optic Nerve / drug effects*
  • Visual Fields / drug effects*

Substances

  • Calcium Channel Blockers
  • Nifedipine